NCCN 21st Annual Conference: Advancing the Standard of Cancer Care™

Course description

The NCCN Annual Conference: Advancing the Standard of Cancer Care™ attracts more than 1,700 registrants from across the United States and the globe including oncologists (in both community and academic settings), oncology fellows, nurses, pharmacists, and other health care professionals involved in the care of patients with cancer. Respected opinion leaders present the latest cancer therapies and provide updates on selected NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), the data upon which the NCCN Guidelines® are based, and quality initiatives in oncology. Topics change annually but focus on the major cancers and supportive care areas.

Target audience: 

This educational program is designed to meet the educational needs of medical, surgical, and radiation oncologists; nurses; physician assistants; pharmacists; case managers; tumor registrars; pathologists; and other healthcare professionals who manage patients with cancer.

Learning objectives: 

Following this program, participants should be able to:

  • Summarize key updates of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and as appropriate integrate these strategies into the management of patients with breast, cervical, GI, GU, non-small cell lung, pancreatic, prostate cancers and CNS, hematologic malignancies, and melanoma to optimize patient outcomes
  • Evaluate current therapeutic advances and emerging clinical trials data and apply relevant findings into the management of patients with cancer
  • Give examples of available tools for cancer risk assessment and explain various recommendations for cancer screening
  • Identify opportunities for improved clinician-patient communication and shared decision making when treating patients with cancer
  • Analyze the data in clinical cancer research presented via the NCCN Foundation’s Young Investigator Awards

Event date:

03/31/2016 - 8:00am
04/02/2016 - 3:00pm
The Diplomat
3555 South Ocean Drive
Hollywood, FL 33019
United States
Credits & accreditation

National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.

National Comprehensive Cancer Network designates this live activity for a maximum of 16.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation. NCCN designates this educational activity for a maximum of 16.75 contact hours. Accreditation as a provider refers to the recognition of educational activities only; accredited status does not imply endorsement by NCCN or ANCC of any commercial products discussed/displayed in conjunction with the educational activity.

Kristina M. Gregory, RN, MSN, OCN, is our lead nurse planner for this educational activity.


National Comprehensive Cancer Network is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Type of Activity: Knowledge

National Comprehensive Cancer Network designates this continuing education activity for 16.75 contact hour(s) (1.675 CEUs) of continuing education credit in states that recognize ACPE-accredited providers.

Universal Activity Numbers: 0836-0000-16-024-L01-P through 0836-0000-16-049-L01-P

Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 16.75 hours of Category I credit for completing this program.

Cancer Registrars
This program supports 16.75 CE hours and has been assigned the following event number: 2016-033.

Case Managers
This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers. The course is approved for 16.75 CE contact hours.
Activity code: C00020585
Approval Number: 160001377

Faculty & disclosure

All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

Additional information

Supported by educational grants from:

  • AstraZeneca
  • BTG
  • Celgene Corporation
  • Clovis Oncology
  • Genentech
  • Genomic Health, Inc.
  • Gilead Sciences, Medical Affairs
  • Lilly
  • Merrimack Pharmaceuticals, Inc.
  • Novartis Oncology
  • Pfizer
  • Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
  • Taiho Oncology
  • Takeda Oncology

This activity is supported by educational funding provided by Amgen.

This activity is supported by an independent medical education grant from Bristol-Myers Squibb.

This activity is supported by independent educational grants from:

  • AbbVie
  • Astellas and Medivation, Inc.
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Incyte
  • Merck
Course summary
Available credit: 
  • 16.75 NCRA CE hours
  • 16.75 CCM clock hours
  • 16.75 ACPE contact hours
  • 16.75 ANCC contact hours
  • 16.75 AMA PRA Category 1 Credit™
  • 16.75 Participation
Course opens: 
Course expires: 
Event starts: 
03/31/2016 - 8:00am
Event ends: 
04/02/2016 - 3:00pm
Enrollments are closed.
Please login or register to take this course.